PRIFTIN

This brand name is authorized in United States. It is also authorized in Estonia, Hong Kong SAR China, Singapore, South Africa.

Active ingredients

The drug PRIFTIN contains one active pharmaceutical ingredient (API):

1	Rifapentine UNII XJM390A33U - RIFAPENTINE
	Rifapentine, a cyclopentyl rifamycin, is an antimycobacterial agent. Rifapentine inhibits DNA-dependent RNA polymerase in susceptible strains of Mycobacterium tuberculosis but not in mammalian cells. At therapeutic levels, rifapentine exhibits bactericidal activity against both intracellular and extracellular M. tuberculosis organisms.
	Read more about Rifapentine

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
PRIFTIN Film-coated tablet	MPI, US: SPL/PLR	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J04AB05	Rifapentine	J Antiinfectives for systemic use → J04 Antimycobacterials → J04A Drugs for treatment of tuberculosis → J04AB Antibiotics
Discover more medicines within J04AB05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1755457
HK	Department of Health Drug Office	65512
SG	Health Sciences Authority	15793P
US	FDA, National Drug Code	0088-2100, 0088-2102, 50090-5063
ZA	Health Products Regulatory Authority	51/20.2.3/1081